US Patent Issued to ADS Therapeutics on May 12 for "Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugs" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,893, issued on May 12, was assigned to ADS Therapeutics LLC.

"Alpha2 adrenergic agonist codrugs conjugated with muscarinic agonist drugs" was invented by Wenkui Ken Fang (Irvine, Calif.), Jinsong Ni (Irvine, Calif.), Rong Yang (Irvine, Calif.) and Van Dinh (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A co-drug or a pharmaceutical salt thereof includes a muscarinic agonist moiety and an alpha2 adrenergic agonist moiety. The muscarinic agonist moiety and the alpha2 adrenergic agonist moiety are connected covalently via a linker, and the link includes an ester bond, an amide bond, a carbamate bond, or a combination thereof."

The paten...